B. Permanetter

528 total citations
26 papers, 415 citations indexed

About

B. Permanetter is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, B. Permanetter has authored 26 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B. Permanetter's work include Cardiovascular Function and Risk Factors (10 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiac Imaging and Diagnostics (3 papers). B. Permanetter is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiac Imaging and Diagnostics (3 papers). B. Permanetter collaborates with scholars based in Germany, Switzerland and United States. B. Permanetter's co-authors include Gert Baumann, Markus Schwaiger, Stephan G. Nekolla, Rolf Bünger, Martin Ungerer, Frank M. Bengel, E. Gerlach, Bernhard F. Becker, A Wirtzfeld and H Blömer and has published in prestigious journals such as CHEST Journal, European Heart Journal and Pharmacology & Therapeutics.

In The Last Decade

B. Permanetter

24 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Permanetter Germany 11 163 148 78 57 48 26 415
Herdson Pb 11 197 1.2× 192 1.3× 104 1.3× 65 1.1× 30 0.6× 18 622
Ann F.C. Roberts United Kingdom 8 105 0.6× 153 1.0× 70 0.9× 85 1.5× 21 0.4× 12 435
Traci Vogel United States 6 106 0.7× 258 1.7× 63 0.8× 240 4.2× 22 0.5× 7 445
U Keller Germany 10 291 1.8× 197 1.3× 29 0.4× 52 0.9× 13 0.3× 32 525
M. Frey Germany 13 143 0.9× 244 1.6× 73 0.9× 118 2.1× 8 0.2× 34 546
K. Wakitani Japan 11 192 1.2× 157 1.1× 33 0.4× 45 0.8× 10 0.2× 15 475
G. Deleeuw United States 5 183 1.1× 187 1.3× 103 1.3× 89 1.6× 11 0.2× 6 503
Hung Cao-Danh United States 16 205 1.3× 259 1.8× 43 0.6× 63 1.1× 16 0.3× 26 549
Emmanuelle Sentex Canada 13 209 1.3× 359 2.4× 55 0.7× 66 1.2× 31 0.6× 16 522
Mariangela Sebastiani Italy 10 340 2.1× 125 0.8× 16 0.2× 95 1.7× 23 0.5× 10 564

Countries citing papers authored by B. Permanetter

Since Specialization
Citations

This map shows the geographic impact of B. Permanetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Permanetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Permanetter more than expected).

Fields of papers citing papers by B. Permanetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Permanetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Permanetter. The network helps show where B. Permanetter may publish in the future.

Co-authorship network of co-authors of B. Permanetter

This figure shows the co-authorship network connecting the top 25 collaborators of B. Permanetter. A scholar is included among the top collaborators of B. Permanetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Permanetter. B. Permanetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Achenbach, Stephan, Werner Moshage, Simone Graf, K. Bachmann, & B. Permanetter. (2009). Magnetocardiographic Parameters for the Detection of Graft Rejection after Heart Transplantation. Biomedizinische Technik/Biomedical Engineering. 303–304. 1 indexed citations
2.
Bengel, Frank M., B. Permanetter, Martin Ungerer, Stephan G. Nekolla, & Markus Schwaiger. (2001). Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart. European Journal of Nuclear Medicine and Molecular Imaging. 29(2). 198–202. 27 indexed citations
3.
Bengel, Frank M., B. Permanetter, Martin Ungerer, Stephan G. Nekolla, & Markus Schwaiger. (2000). Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate - comparison between the normal and failing human heart. European Journal of Nuclear Medicine and Molecular Imaging. 27(3). 319–326. 51 indexed citations
4.
Pfafferott, C., et al.. (1997). Atypical Kawasaki syndrome: how many symptoms have to be present?. Heart. 78(6). 619–621. 12 indexed citations
5.
Massoudy, Parwis, et al.. (1993). [Possible significance of free oxygen radicals for reperfusion injury].. PubMed. 82 Suppl 5. 49–58. 5 indexed citations
6.
Permanetter, B., et al.. (1992). Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. European Heart Journal. 13(11). 1528–1533. 66 indexed citations
7.
Becker, Bernhard F., et al.. (1991). Role of Uric Acid as an Endogenous Radical Scavenger and Antioxidant. CHEST Journal. 100(3). 176S–181S. 78 indexed citations
8.
Baumann, Gert, et al.. (1989). Clinical Efficacy of Pimobendan (UD-CG 115 BS) in Patients with Chronic Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 14(Supplement). S31–S31. 6 indexed citations
9.
Permanetter, B., et al.. (1989). Effect of Intravenous Pimobendan (UDCG 115 BS) on Hemodynamics and Left Ventricular Volumes in Idiopathic Dilative Cardiomyopathy. Journal of Cardiovascular Pharmacology. 14(6). 803–809. 5 indexed citations
10.
Permanetter, B., et al.. (1989). Acute Effects of Intraveneous UD-CG 115 BS (Pimobendan) on the Cardiovascular System and Left Ventricular Pump Function. Journal of Cardiovascular Pharmacology. 14(Supplement). S41–S41. 7 indexed citations
12.
Permanetter, B., H Sebening, S. Hagl, et al.. (1989). [The significance of heart rate for stress hemodynamics following heart transplantation].. PubMed. 78(4). 236–42. 2 indexed citations
13.
Permanetter, B., et al.. (1989). [Lack of effectiveness of coenzyme Q10 (ubiquinone) in long-term treatment of dilated cardiomyopathy].. PubMed. 78(6). 360–5. 2 indexed citations
14.
Permanetter, B., et al.. (1989). [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].. PubMed. 78(5). 335–42. 1 indexed citations
15.
Busch, Ulrich, H Sebening, Ulrich Renner, B. Permanetter, & H Blömer. (1987). Twelve year follow-up in Kawasaki disease (mucocutaneous lymph node disease). European Heart Journal. 8(suppl J). 77–79. 1 indexed citations
16.
Permanetter, B., et al.. (1985). Effects of three histaminergic compounds on function and oxygen consumption of isolated guinea-pig hearts. Inflammation Research. 16(3-4). 215–218. 4 indexed citations
17.
Baumann, Gert, B. Permanetter, & A Wirtzfeld. (1984). Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure. Pharmacology & Therapeutics. 24(2). 165–177. 39 indexed citations
18.
Bünger, Rolf & B. Permanetter. (1984). Parallel stimulation by Ca2+ of inotropism and pyruvate dehydrogenase in perfused heart. American Journal of Physiology-Cell Physiology. 247(1). C45–C52. 24 indexed citations
19.
Berdel, Wolfgang E., U. Fink, P. Maubach, B. Permanetter, & Johann Rastetter. (1982). Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. Annals of Hematology. 44(3). 177–186. 8 indexed citations
20.
Bünger, Rolf, et al.. (1982). Adaptive changes of pyruvate oxidation in perfused heart during adrenergic stimulation. American Journal of Physiology-Heart and Circulatory Physiology. 242(1). H30–H36. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026